Canopy Biosciences aims to capitalize on Sequencing Error-Correction
/Canopy Biosciences Aims to Improve Rare Variant Detection With Error-Correction Sequencing Service
NEW YORK (GenomeWeb) – After receiving an exclusive license from the Washington University in St. Louis for its error-correction sequencing technology, startup Canopy Biosciences now plans to develop the bioinformatic tool further to identify and monitor ultra-rare gene variants in patient blood samples.
With the new license, Canopy will build upon its gene expression analysis portfolio by offering a streamlined research-use-only service for next-generating sequencing applications.
